We use cookies to improve your experience on this website. Read More Allow Cookies


24 September, 2019

Galway based Medtech Company, Vivasure Medical Ltd. is the latest Irish company to agree Venture Debt financing with the European Investment Bank.

The second long-term EIB financing for an Irish medical technology company was confirmed ahead of a briefing for Irish business leaders on new innovation financing opportunities supported by the EU Bank.

Company representatives and innovation partners were briefed on new tailor made EIB financing at workshop in Dublin hosted by IBEC and the EIB, part of a series of corporate finance briefings being held across Ireland.

The €10 million new financing will be used by Vivasure to expand research and development of medical devices to provide non-invasive cardiology treatment. Vivasure has developed pioneering non-invasive biodegradable devices to treat cardiology patients with conditions that require vascular surgery.

Last year, the European Investment Bank Group provided €970m of long-term financing to strengthen higher education, improve healthcare, transform transport and harness clean energy across Ireland, as well as enhancing corporate research and innovation.

For more information click HERE.